Scholarlink

<p>Newborn mammals transiently maintain the heart regenerative capacity. β-adrenergic receptor (β-AR) is the most critical receptor in regulating cardiomyocyte behavior. However, the role and mechanism of β-AR, especially the subtypes of β-AR, in heart regeneration remain unclear. Here, we reveal that β-AR inhibits heart regeneration by downregulating <i>Yap</i> m6A modification. The β-AR expression is associated with heart regenerative capacity. After apical resection, β-AR (including β<sub>1</sub>-AR and β<sub>2</sub>-AR) inhibits heart regeneration. β<sub>2</sub>-AR exerts a more potent inhibitory effect compared with β<sub>1</sub>-AR. Mechanistically, both β<sub>1</sub>-AR and β<sub>2</sub>-AR downregulate <i>Yap</i> m6A modification and then YAP expression differentially by reducing METTL14 and IGF2BP1, respectively. Elevation of <i>Yap</i> m6A modification with adenoviruses encoding METTL14 and IGF2BP1 rescues YAP expression and cardiomyocyte proliferation inhibited by β<sub>1</sub>-AR and β<sub>2</sub>-AR, respectively. These findings indicate that both β<sub>1</sub>-AR and β<sub>2</sub>-AR inhibit heart regeneration in a m6A-dependent manner and reveal subtype-specific mechanism. These results will provide a new intervention strategy for heart regeneration.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

β-adrenergic receptor inhibits heart regeneration by downregulating Yap m6A modification

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月14日

查看全文
  • Kaihang Guan,
  • Zijian Li

摘要

Newborn mammals transiently maintain the heart regenerative capacity. β-adrenergic receptor (β-AR) is the most critical receptor in regulating cardiomyocyte behavior. However, the role and mechanism of β-AR, especially the subtypes of β-AR, in heart regeneration remain unclear. Here, we reveal that β-AR inhibits heart regeneration by downregulating Yap m6A modification. The β-AR expression is associated with heart regenerative capacity. After apical resection, β-AR (including β1-AR and β2-AR) inhibits heart regeneration. β2-AR exerts a more potent inhibitory effect compared with β1-AR. Mechanistically, both β1-AR and β2-AR downregulate Yap m6A modification and then YAP expression differentially by reducing METTL14 and IGF2BP1, respectively. Elevation of Yap m6A modification with adenoviruses encoding METTL14 and IGF2BP1 rescues YAP expression and cardiomyocyte proliferation inhibited by β1-AR and β2-AR, respectively. These findings indicate that both β1-AR and β2-AR inhibit heart regeneration in a m6A-dependent manner and reveal subtype-specific mechanism. These results will provide a new intervention strategy for heart regeneration.